Search research articles
Contact Us
Filters
Showing results (491-500 of 527) with videos related to
Page
of 53
Sort By:
International Journal of Rheumatic Diseases
|
May 14, 2024
Characteristics of emerging new autoimmune diseases after COVID-19 vaccination: A sub-study by the COVAD group
Russka Shumnalieva, Naveen Ravichandran, Jennifer Hannah, et al.
Lancet Regional Health. Americas
|
March 12, 2026
Clinical and molecular characterization of a large Brazilian lung cancer cohort: a real-world observational study
Rodrigo de Oliveira Cavagna, Flávia Escremim de Paula, Gustavo Noriz Berardinelli, et al.
Rheumatology Advances in Practice
|
March 25, 2024
Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey
Akira Yoshida, Yuan Li, Vahed Maroufy, et al.
Rheumatology (Oxford, England)
|
April 26, 2025
Consensus nomenclature and abbreviation for anti-synthetase syndrome: an IMACS project
Anushka Aggarwal, Tanya Chandra, Shiri Keret, et al.
Journal of Translational Autoimmunity
|
January 1, 2024
Long-term outcomes of COVID-19 vaccination in patients with rare and complex connective tissue diseases: The ERN-ReCONNET VACCINATE study
Chiara Tani, Chiara Cardelli, Roberto Depascale, et al.
Lupus Science & Medicine
|
May 4, 2026
Efficacy of belimumab in patients with SLE and haematological manifestations: retrospective analysis from the BeRLiSS 2.0 cohort
Greta Hulej, Federico Arru, Benedetta Bianchi, et al.
The Lancet. Rheumatology
|
January 24, 2026
Patient partnership model in rare and complex rheumatological conditions: research and beyond in European Reference Network ReCONNET
Jeanette Andersen, Rosaria Talaric, Diana Marinello, et al.
RMD Open
|
March 20, 2019
Idiopathic inflammatory myopathies: state of the art on clinical practice guidelines [corrected]
Alain Meyer, Carlo Alberto Scirè, Rosaria Talarico, et al.
Scientific Reports
|
October 13, 2025
Factors influencing the choice of non-biologic versus biologic immunosuppressive therapy in systemic lupus erythematosus
Alessandra Bortoluzzi, Antonio Marangoni, Ettore Silvagni, et al.
Joint Bone Spine
|
December 10, 2020
HLA association with the susceptibility to anti-synthetase syndrome
Sara Remuzgo-Martínez, Belén Atienza-Mateo, J Gonzalo Ocejo-Vinyals, et al.
Page
of 53
Search research articles
Search
Showing results (491-500 of 527) with videos related to
Sort By:
Page
of 53
International Journal of Rheumatic Diseases
|
May 14, 2024
Characteristics of emerging new autoimmune diseases after COVID-19 vaccination: A sub-study by the COVAD group
Russka Shumnalieva, Naveen Ravichandran, Jennifer Hannah, et al.
Lancet Regional Health. Americas
|
March 12, 2026
Clinical and molecular characterization of a large Brazilian lung cancer cohort: a real-world observational study
Rodrigo de Oliveira Cavagna, Flávia Escremim de Paula, Gustavo Noriz Berardinelli, et al.
Rheumatology Advances in Practice
|
March 25, 2024
Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey
Akira Yoshida, Yuan Li, Vahed Maroufy, et al.
Rheumatology (Oxford, England)
|
April 26, 2025
Consensus nomenclature and abbreviation for anti-synthetase syndrome: an IMACS project
Anushka Aggarwal, Tanya Chandra, Shiri Keret, et al.
Journal of Translational Autoimmunity
|
January 1, 2024
Long-term outcomes of COVID-19 vaccination in patients with rare and complex connective tissue diseases: The ERN-ReCONNET VACCINATE study
Chiara Tani, Chiara Cardelli, Roberto Depascale, et al.
Lupus Science & Medicine
|
May 4, 2026
Efficacy of belimumab in patients with SLE and haematological manifestations: retrospective analysis from the BeRLiSS 2.0 cohort
Greta Hulej, Federico Arru, Benedetta Bianchi, et al.
The Lancet. Rheumatology
|
January 24, 2026
Patient partnership model in rare and complex rheumatological conditions: research and beyond in European Reference Network ReCONNET
Jeanette Andersen, Rosaria Talaric, Diana Marinello, et al.
RMD Open
|
March 20, 2019
Idiopathic inflammatory myopathies: state of the art on clinical practice guidelines [corrected]
Alain Meyer, Carlo Alberto Scirè, Rosaria Talarico, et al.
Scientific Reports
|
October 13, 2025
Factors influencing the choice of non-biologic versus biologic immunosuppressive therapy in systemic lupus erythematosus
Alessandra Bortoluzzi, Antonio Marangoni, Ettore Silvagni, et al.
Joint Bone Spine
|
December 10, 2020
HLA association with the susceptibility to anti-synthetase syndrome
Sara Remuzgo-Martínez, Belén Atienza-Mateo, J Gonzalo Ocejo-Vinyals, et al.
Page
of 53